Patients with FLT3/ITD AML May Benefit From Allogeneic Transplant In First Remission: Outcomes From a Consecutive Series of Patients at a Single Institution
Publication
, Conference
DeZern, AE; Sung, A; Kim, S; Tsai, H-L; Kowalski, J; Smith, BD; Karp, JE; Gore, SD; Fuchs, E; McDevitt, MA; Luznik, L; Jones, RJ; Levis, MJ
Published in: BLOOD
2010
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
2010
Volume
116
Issue
21
Start / End Page
896 / 897
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
DeZern, A. E., Sung, A., Kim, S., Tsai, H.-L., Kowalski, J., Smith, B. D., … Levis, M. J. (2010). Patients with FLT3/ITD AML May Benefit From Allogeneic Transplant In First Remission: Outcomes From a Consecutive Series of Patients at a Single Institution. In BLOOD (Vol. 116, pp. 896–897).
DeZern, Amy E., Anthony Sung, Sharon Kim, Hua-Ling Tsai, Jeanne Kowalski, B Douglas Smith, Judith E. Karp, et al. “Patients with FLT3/ITD AML May Benefit From Allogeneic Transplant In First Remission: Outcomes From a Consecutive Series of Patients at a Single Institution.” In BLOOD, 116:896–97, 2010.
DeZern AE, Sung A, Kim S, Tsai H-L, Kowalski J, Smith BD, et al. Patients with FLT3/ITD AML May Benefit From Allogeneic Transplant In First Remission: Outcomes From a Consecutive Series of Patients at a Single Institution. In: BLOOD. 2010. p. 896–7.
DeZern, Amy E., et al. “Patients with FLT3/ITD AML May Benefit From Allogeneic Transplant In First Remission: Outcomes From a Consecutive Series of Patients at a Single Institution.” BLOOD, vol. 116, no. 21, 2010, pp. 896–97.
DeZern AE, Sung A, Kim S, Tsai H-L, Kowalski J, Smith BD, Karp JE, Gore SD, Fuchs E, McDevitt MA, Luznik L, Jones RJ, Levis MJ. Patients with FLT3/ITD AML May Benefit From Allogeneic Transplant In First Remission: Outcomes From a Consecutive Series of Patients at a Single Institution. BLOOD. 2010. p. 896–897.
Published In
BLOOD
ISSN
0006-4971
Publication Date
2010
Volume
116
Issue
21
Start / End Page
896 / 897
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology